In CSF, however, the day-by-day release of NPY was significantly increased in the SAH group compared to the intracerebral hemorrhage group and the control group, indicating that the hypersecretion of NPY into CSF, but not into serum, is specific for SAH (21). The gene discussed is NPY; the disease is intracerebral hemorrhage.